Auro Labs - Auro Laboratories Share Price

  • 186.05-7.80 (-4.02%)
  • Volume: 14,587
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:44 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Auro Labs - Auro Labora...

  • 186.05-7.80 (-4.02%)
  • Volume: 14,587
Advertisment

Auro Labs share price insights

View All

  • Company delivered ROE of 18.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 15.41%. (Source: Standalone Financials)

  • Company witnessed QoQ revenue decline of 52.47%, which is lowest in the last 3 years. (Source: Standalone Financials)

  • Company has spent 1.37% of its operating revenues towards interest expenses and 9.59% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Auro Laboratories Ltd. share price moved down by -4.02% from its previous close of Rs 193.85. Auro Laboratories Ltd. stock last traded price is 186.05

    Share PriceValue
    Today/Current/Last-186.05
    Previous Day-193.85

InsightsAuro Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		14.91
    EPS - TTM
    (₹)    		12.48
    MCap
    (₹ Cr.)    		115.96
    Sectoral MCap Rank
    		131
    PB Ratio
    (x)    		2.88
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.43
    3 Months0.64
    6 Months0.50
    1 Year0.51
    3 Years0.99

    		0.43
    VWAP
    (₹)    		187.66
    52W H/L
    (₹)
    307.20 / 105.20

    Auro Labs Share Price Returns

    1 Day-4.02%
    1 Week-7.55%
    1 Month5.56%
    3 Months-10.49%
    1 Year57.27%
    3 Years44.39%
    5 Years264.09%

    ET Stock ScreenersTop Score Companies

    Check whether Auro Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Auro Labs News & Analysis

    View all Auro Labs Share News & Announcements

    Auro Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Auro Labs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Auro Labs Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 52.47%, which is lowest in the last 3 years. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 1.37% of its operating revenues towards interest expenses and 9.59% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income5.9212.4618.4013.7310.55
      Total Income Growth (%)-52.47-32.2834.0330.17-25.43
      Total Expenses4.679.9414.1710.659.30
      Total Expenses Growth (%)-53.02-29.8832.9814.57-18.98
      EBIT1.262.534.233.081.25
      EBIT Growth (%)-50.28-40.3237.64146.46-53.20
      Profit after Tax (PAT)0.752.322.731.970.71
      PAT Growth (%)-67.57-15.1238.92178.14-60.31
      EBIT Margin (%)21.2020.2723.0022.4011.83
      Net Profit Margin (%)12.7118.6214.8614.336.71
      Basic EPS (₹)1.213.724.393.161.14
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue55.1453.8451.9655.0144.76
      Total Revenue Growth (%)2.423.61-5.5522.89-6.32
      Total Expenses44.7950.3948.0844.5039.12
      Total Expenses Growth (%)-11.114.798.0413.76-6.21
      Profit after Tax (PAT)7.792.442.847.184.05
      PAT Growth (%)219.09-14.16-60.3877.08-7.84
      Operating Profit Margin (%)20.668.059.2420.2013.94
      Net Profit Margin (%)14.524.615.5913.239.25
      Basic EPS (₹)12.503.924.5611.526.51

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets85.7355.9954.9641.8932.35
      Total Assets Growth (%)53.121.8731.2029.49-3.35
      Total Liabilities43.7721.7923.4413.3110.85
      Total Liabilities Growth (%)100.87-7.0476.1122.67-32.40
      Total Equity41.9634.2031.5228.5821.50
      Total Equity Growth (%)22.698.5010.2932.9323.49
      Current Ratio (x)1.291.971.873.322.93
      Total Debt to Equity (x)0.630.180.030.070.08
      Contingent Liabilities3.694.453.155.962.89

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 38.67 cr for investing activities which is an YoY increase of 661.03%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities18.813.28-6.595.809.19
      Net Cash used in Investing Activities-38.67-5.08-5.343.51-2.21
      Net Cash flow from Financing Activities19.09-8.189.79-0.46-5.40
      Net Cash Flow-0.77-9.98-2.148.851.58
      Closing Cash & Cash Equivalent1.652.4212.4014.545.68
      Closing Cash & Cash Equivalent Growth (%)-31.78-80.50-14.73155.7338.38
      Total Debt/ CFO (x)1.401.88-0.130.350.20

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 18.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 15.41%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)18.577.149.0225.1118.86
      Return on Capital Employed (%)17.9311.2513.4932.8023.30
      Return on Assets (%)9.084.365.1717.1312.53
      Interest Coverage Ratio (x)16.556.556.9223.9213.10
      Asset Turnover Ratio (x)0.760.951.05129.50135.37
      Price to Earnings (x)12.9013.9521.987.044.84
      Price to Book (x)2.391.001.981.770.91
      EV/EBITDA (x)10.277.098.913.172.21
      EBITDA Margin (%)22.6910.0811.2422.1116.28

      No reported Financial Ratios are available.

    Financial InsightsAuro Labs

    • Income (P&L)
    • Cash Flow
    • Ratios

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 52.47%, which is lowest in the last 3 years. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent 1.37% of its operating revenues towards interest expenses and 9.59% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 38.67 cr for investing activities which is an YoY increase of 661.03%. (Source: Standalone Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 18.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 15.41%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Auro Labs Peer Comparison

    • Auro Labs Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Auro Labs14.912.7618.5717.939.080.0820.6614.5212.501.290.631.40
          MadhuveerCom181,502.7110.927.437.915.83266.2962.0248.172.469.550.217.25
          Source Natural77.687.548.9217.087.342.6512.536.362.704.980.000.00
          Aayush Food & Herbs197.0529.6411.6311.9711.39-82.0098.2894.831.768.010.000.00
          Parnax Lab13.181.8913.4216.265.0927.739.215.108.380.920.994.48
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Samrat Pharma
          • Mercury Laboratories
          • Bharat Immunological
          • Everest Org
          • Biofil Chem

          Choose from Stocks

            See All Parameters

          Peers InsightsAuro Labs

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Auro Labs Shareholding Pattern

            • QOQ Change

            • Total Shareholdings

            • Loading...
              Showing Auro Labs Shareholding as on 30 Jun 2024
              Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
              Promoters52.1552.1552.0952.09
              Pledge0.000.000.000.00
              FII0.000.000.000.00
              DII0.010.010.010.01
              Mutual Funds0.010.010.010.01
              Others47.8447.8447.9047.90
            • Showing Shareholding as on 30 Jun 2024
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters32,50,31052.15 %0.00
              Pledge00.00 %0.00
              DII4000.01 %0.00
              MF4000.01 %0.00
              Others29,81,79047.84 %0.00

            MF Ownership

            MF Ownership details are not available.

            Top Searches:

            Auro Labs News Auro Labs Quarterly Results Auro Labs Dividend Auro Labs Q1 ResultsAuro Labs Q2 ResultsAuro Labs Q3 ResultsAuro Labs Q4 Results

            Corporate Actions

            • Auro Labs Board Meeting/AGM

            • Auro Labs Dividends

            • Others
            • Meeting DateAnnounced onPurposeDetails
              Aug 09, 2024Jul 31, 2024Board MeetingQuarterly Results
              May 25, 2024May 17, 2024Board MeetingAudited Results
              Feb 06, 2024Jan 31, 2024Board MeetingQuarterly Results
              Nov 09, 2023Nov 03, 2023Board MeetingQuarterly Results
              Sep 23, 2023Aug 23, 2023AGM-
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final -0.0-Sep 07, 2002

            • No other corporate actions details are available.

            About Auro Labs

            Auro Laboratories Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 115.96 Crore) operating in Pharmaceuticals sector. Auro Laboratories Ltd. key Products/Revenue Segments include Metformin Hydrochloride, Export Incentives for the year ending 31-Mar-2023. Show More

            • Executives

            • Auditors

            • SD

              Sharat Deorah

              Chairman & Managing Director
              KS

              Kiran Suresh Kulkarni

              Whole Time Director
              SD

              Siddhartha Deorah

              Whole Time Director
              KV

              Kavita Vijayakant Sharma

              Ind. Non-Executive Director
              Show More
            • Kothari Jain & Associates
              Khurdia Jain & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            K-56, M.I.D.C. Industrial Area,Tarapur, Boisar,Palghar District, Maharashtra - 401506

            Contact

            [email protected]

            http://www.aurolabs.com

            More Details

            FAQs about Auro Labs share

            • 1. What is Auro Labs share price and what are the returns for Auro Labs share?
              As on 29 Aug, 2024, 03:44 PM IST Auro Labs share price was down by 4.02% basis the previous closing price of Rs 194.35. Auro Labs share price was Rs 186.05. Return Performance of Auro Labs Shares:
              • 1 Week: Auro Labs share price moved down by 7.55%
              • 3 Month: Auro Labs share price moved down by 10.49%
              • 6 Month: Auro Labs share price moved up by 14.60%
            • 2. Who owns Auro Labs?
                • Promoter holding has gone up from 52.09 (30 Sep 2023) to 52.15 (30 Jun 2024)
                • Domestic Institutional Investors holding has not changed in last 9 months and holds 0.01 stake as on 30 Jun 2024
                • Other investor holding have gone down from 47.9 (30 Sep 2023) to 47.84 (30 Jun 2024)
            • 3. Who are the peers for Auro Labs in Pharmaceuticals sector?
              Top 10 Peers for Auro Labs are Parnax Lab Ltd., Everest Organics Ltd., Mercury Laboratories Ltd., Source Natural Foods & Herbal Supplements Ltd., Madhuveer Com 18 Network Ltd., Biofil Chemicals & Pharmaceuticals Ltd., Samrat Pharmachem Ltd., Aayush Wellness Ltd., Makers Laboratories Ltd. and Bharat Immunological & Biologicals Corporation Ltd.
            • 4. What are the Auro Labs quarterly results?
              Total Revenue and Earning for Auro Labs for the year ending 2024-03-31 was Rs 55.14 Cr and Rs 7.79 Cr on Standalone basis. Last Quarter 2024-06-30, Auro Labs reported an income of Rs 5.92 Cr and profit of Rs 0.75 Cr.
            • 5. What's the market capitalization of Auro Labs?
              Auro Labs share has a market capitalization of Rs 115.96 Cr. Within Pharmaceuticals sector, it's market cap rank is 131.
            • 6. Who's the chairman of Auro Labs?
              Sharat Deorah is the Chairman & Managing Director of Auro Labs
            • 7. What are the key metrics to analyse Auro Labs Share Price?
              Auro Labs share can be quickly analyzed on following metrics:
              • Stock's PE is 14.91
              • Price to Book Ratio of 2.88
            • 8. What dividend is Auro Labs giving?
              No dividend has been report for Auro Laboratories Ltd..
            • 9. What are the returns for Auro Labs share?
              Return Performance of Auro Labs Shares:
              • 1 Week: Auro Labs share price moved down by 7.55%
              • 3 Month: Auro Labs share price moved down by 10.49%
              • 6 Month: Auro Labs share price moved up by 14.60%
            • 10. What is the PE & PB ratio of Auro Labs?
              The PE ratio of Auro Labs stands at 15.52, while the PB ratio is 2.88.
            • 11. What has been highest price of Auro Labs share in last 52 weeks?
              Auro Labs share price saw a 52 week high of Rs 307.20 and 52 week low of Rs 105.20.
            • 12. What is the CAGR of Auro Labs?
              The CAGR of Auro Labs is -0.29.

            Trending in Markets

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Auro Labs Share Price
            The Economic Times